CVSA logo

Covista Inc. Stock Price

NYSE:CVSA Community·US$4.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 27 Fair Values set on narratives written by author

CVSA Share Price Performance

US$130.90
12.13 (10.21%)
US$153.25
Fair Value
US$130.90
12.13 (10.21%)
14.6% undervalued intrinsic discount
US$153.25
Fair Value
Price US$130.90
AnalystConsensusTarget US$153.25
AnalystLowTarget US$140.00
AnalystHighTarget US$175.00

CVSA Community Narratives

·
Fair Value US$153.25 14.6% undervalued intrinsic discount

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$140 6.5% undervalued intrinsic discount

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$175 25.2% undervalued intrinsic discount

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$140
6.5% undervalued intrinsic discount
Revenue
7.6% p.a.
Profit Margin
14.85%
Future PE
13.78x
Price in 2029
US$168.65
US$153.25
14.6% undervalued intrinsic discount
Revenue
6.99% p.a.
Profit Margin
15.08%
Future PE
16.6x
Price in 2029
US$189.37
US$175
25.2% undervalued intrinsic discount
Revenue
7.45% p.a.
Profit Margin
16.24%
Future PE
17.43x
Price in 2029
US$216.88

Trending Discussion

Updated Narratives

CVSA logo

CVSA: Student Enrollment Momentum And Campus Expansion Will Support Future Upside

Fair Value: US$140 6.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CVSA logo

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

Fair Value: US$153.25 14.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CVSA logo

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

Fair Value: US$175 25.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet and fair value.

1 Risk
3 Rewards

Covista Inc. Key Details

US$1.9b

Revenue

US$815.8m

Cost of Revenue

US$1.1b

Gross Profit

US$844.3m

Other Expenses

US$249.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
7.34
57.28%
13.07%
36.6%
View Full Analysis

About CVSA

Founded
1987
Employees
4727
CEO
Stephen Beard
WebsiteView website
www.covista.com

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor’s, master’s, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Recent CVSA News & Updates

Narrative Update Jun 26

CVSA: Student Enrollment Momentum And Campus Expansion Will Support Future Upside

The analyst price target for Covista has increased from $130 to $140, with analysts citing updated assumptions on revenue growth, profit margins, and future P/E as the key reasons for the change. What’s in the News for Covista Covista raised its fiscal 2026 revenue guidance to a range of approximately US$1.93b to US$1.945b, compared with the prior range of US$1.9b to US$1.94b, with guidance implying about 8% to 9% year-over-year growth.

Recent updates

No updates